Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproterone Acetate for Hot Flashes in Prostate Cancer
NCT00005623Phase 3Completed
- Sponsor
- AG Barr
- Start
- Dec 1999
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cyproterone in hot flashes (3 arms), sponsored by AG Barr. Primary endpoint: Efficacy of cyproterone acetate in treating hot flashes at 12 weeks. Started Dec 1999; status: completed.
02
Drugs
cyproterone
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT00005623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005623.